Fokus på finansiering och IMI 2.0

Med IMI 2.0 i antågande diskuterade en internationell panel på investerarmässan Bioequity frågan om hur EU-finansiering och riskkapital kan göra Europa konkurre...

Dry blood DNA storage on a matrix

Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...

Diamyd jagar uppköpskandidater

Efter dubbla bakslag ekar det tomt i Diamyds projektportfölj. Med en kassa på nästan 400 miljoner söker bolaget nya strategiska möjligheter.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Köpsugna läkemedelsbolag jagar nya projekt

Köpa eller köpas. Efter marknadsgodkännanden och klirr i kassan cirkulerar rykten om uppköp. Men de svenska forskningsbolagen framhåller att de kommer att stå för köpandet.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Pfizer buys Swiss vaccines

Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.

Brighter till Nasdaq

När börsen öppnades på fredagsmorgonen anslöt ytterligare ett bolag till aktiemarknaden.

Continuous sampling allows for instantaneous microbial detection

Biovigilant's IMD-A instruments employ an optical technology to continuously sample the air and immediately warn when microbial contamination is detected.

Kritiserad organisation stöps om

Nu sjösätts den nya organisationen Business Sweden som ett resultat av att Invest Sweden och Exportrådet slagits samman.

Hallå där Karin Aase...

...projektledare för Swedenbios CSO Summit som hölls för första gången 18 september. Hur gick det?

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Adenovir tar in tio miljoner

Nu ska Puls-bolaget fullfölja sin fas II-studie och förbereda exit.

Medicult acquires embryo scanner

The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

New type of stem cell discovered

The earlier view of the scientific community was that melanocytes, the pigment cells, derive from the spinal cord during the early fetal period and then move ov...

LEO Pharma - International Clinical Trial Manager

Google ger sig in i biotech-branschen

Sökmotorjättens nystartade bolag Calico ska fokusera på åldrande och åldersrelaterade sjukdomar.

Athera signs production partnership

The companys novel cardiovascular product will be manufactured in Germany.

Measurement of calorific content in a matter of minutes

The AC600 calorimeter from Leco uses rapid thermodynamics to analyze calorific content in five minutes.

Sobis forskningschef går till Orexo

Tar över ansvaret för Orexos forskning och utveckling.